日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Neuroimaging‐Based Assessment of Social Cognition in Older Adults with Mild Cognitive Impairment: A Systematic Review

基于神经影像学的轻度认知障碍老年人社会认知评估：系统评价

期刊:Schizophrenia Bulletin
影响因子:4.8
doi:10.1093/schbul/sbt148
Velligan, Dawn I; Fredrick, Megan; Mintz, Jim; Li, Xueying; Rubin, Maureen; Dube, Sanjay; Deshpande, Smita N; Trivedi, Jitendra K; Gautam, Shiv; Avasthi, Ajit; Kern, Robert S; Marder, Stephen R; Han, Gyeomju
神经科学
发表日期：2025
文献求助 收藏

Measuring Cognitive Impairments Associated With Schizophrenia in Clinical Practice: Overview of Current Challenges and Future Opportunities

临床实践中精神分裂症相关认知障碍的测量：当前挑战与未来机遇概述

期刊:Schizophrenia Bulletin
影响因子:4.8
doi:10.1093/schbul/sbae051
Nuechterlein, Keith H; Nasrallah, Henry; Velligan, Dawn
精神分裂症
神经科学
发表日期：2025
文献求助 收藏

Clinician differences in attitudes and perceptions on the use of long-acting injectable antipsychotic agents in treating patients with schizophrenia: results from the US DECIDE survey

临床医生对使用长效注射抗精神病药物治疗精神分裂症患者的态度和看法存在差异：来自美国DECIDE调查的结果

期刊:BMC Psychiatry
影响因子:3.6
doi:10.1186/s12888-025-06565-1
Velligan, Dawn; Salinas, Gregory D; Belcher, Emily; Franzenburg, Kelli R; Suett, Mark; Thompson, Stephen; Hansen, Rolf T 3rd
精神分裂症
神经科学
IDE
发表日期：2025
文献求助 收藏

Preferences for Selecting and Initiating Long-Acting Injectable Antipsychotic Agents for the Treatment of Patients With Schizophrenia: Results From the US DECIDE Survey

美国DECIDE调查结果：选择和启动长效注射抗精神病药物治疗精神分裂症患者的偏好

期刊:Schizophrenia Bulletin Open
影响因子:2
doi:10.1093/schizbullopen/sgaf001
Velligan, Dawn; Salinas, Gregory D; Belcher, Emily; Franzenburg, Kelli R; Suett, Mark; Thompson, Stephen; Hansen, Rolf T 3rd
精神分裂症
神经科学
IDE
发表日期：2025
文献求助 收藏

Treatment Patterns and Outcomes from OASIS: A Prospective Observational Study of Long-Acting Injectables in Schizophrenia

OASIS 的治疗模式和结果：一项关于长效注射剂治疗精神分裂症的前瞻性观察研究

期刊:
影响因子:
doi:10.2147/NDT.S528018
Weiden, Peter J; Strand, Lauren N; Doane, Michael J; Arevalo, Christina; McGrory, James A; Achtyes, Eric D; Harvey, Philip D; Kane, John M; Saklad, Stephen R; Trotter, Jeffrey; Velligan, Dawn I
精神分裂症
神经科学
发表日期：2025
文献求助 收藏

Rationale and Challenges for a New Instrument for Remote Measurement of Negative Symptoms

用于远程测量阴性症状的新仪器的理论依据和挑战

期刊:Schizophrenia Bulletin Open
影响因子:2
doi:10.1093/schizbullopen/sgae027
Daniel, David Gordon; Cohen, Alex S; Harvey, Philip D; Velligan, Dawn I; Potter, William Z; Horan, William P; Moore, Raeanne C; Marder, Stephen R
发表日期：2024
文献求助 收藏

Relationship between social determinants of health and hospitalizations and costs in patients with major depressive disorder

社会健康决定因素与重度抑郁症患者住院治疗及费用之间的关系

期刊:
影响因子:
doi:10.18553/jmcp.2024.30.9.978
Teigland, Christie; Mohammadi, Iman; Agatep, Barnabie C; Boskovic, Dusica Hadzi; Velligan, Dawn
抑郁症
神经科学
发表日期：2024
文献求助 收藏

Unmet needs with antipsychotic treatment in schizophrenia and bipolar I disorder: patient perspectives from qualitative focus groups

精神分裂症和I型双相情感障碍患者抗精神病药物治疗中未满足的需求：来自定性焦点小组的患者视角

期刊:BMC Psychiatry
影响因子:3.6
doi:10.1186/s12888-023-04746-4
Doane, Michael J; Raymond, Kimberly; Saucier, Cory; Bessonova, Leona; O'Sullivan, Amy K; White, Michelle K; Foster, April Mitchell; LaGasse, Kaitlin; Carpenter-Conlin, Julia; Sajatovic, Martha; Velligan, Dawn I
精神分裂症
神经科学
发表日期：2023
文献求助 收藏

Development and validation of a fidelity instrument for Cognitive Adaptation Training

认知适应训练保真度评估工具的开发与验证

期刊:Schizophrenia Research-Cognition
影响因子:3
doi:10.1016/j.scog.2022.100272
van Dam, Michelle; van Weeghel, Jaap; Castelein, Stynke; Stiekema, Annemarie; Quee, Piotr; Kidd, Sean; Allott, Kelly; Maples, Natalie; Velligan, Dawn; Pijnenborg, Marieke; van der Meer, Lisette
神经科学
发表日期：2023
文献求助 收藏

A Pilot Study Examining Feasibility and Initial Efficacy of Remotely Delivered Cognitive Adaptation Training

一项探讨远程认知适应训练可行性及初步效果的试点研究

期刊:Schizophrenia Bulletin Open
影响因子:2
doi:10.1093/schizbullopen/sgad028
Velligan, Dawn I; Li, Feiyu; Sebastian, Veronica; Kennedy, Cory; Mintz, Jim
神经科学
发表日期：2023
文献求助 收藏